Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Davis

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The New England Journal of Medicine|August 9, 1979
Somatostatinoma syndrome. Biochemical, morphologic and clinical featuresG J Krejs, L Orci, J M Conlon, et al.
Journal of Anatomy|August 19, 2014
On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritisA Boyde, G R Davis, D Mills, et al.
Acta Biomaterialia|June 15, 2018
Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral qualityL Xi, P De Falco, E Barbieri, et al.
Bone|November 15, 2019
Reduction of fibrillar strain-rate sensitivity in steroid-induced osteoporosis linked to changes in mineralized fibrillar nanostructureL Xi, P De Falco, E Barbieri, et al.
Immunity|January 26, 2021
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinomaJuan Dubrot, Sarah Kate Lane-Reticker, Emily A Kessler, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The New England Journal of Medicine|August 9, 1979
Somatostatinoma syndrome. Biochemical, morphologic and clinical featuresG J Krejs, L Orci, J M Conlon, et al.
Journal of Anatomy|August 19, 2014
On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritisA Boyde, G R Davis, D Mills, et al.
Acta Biomaterialia|June 15, 2018
Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral qualityL Xi, P De Falco, E Barbieri, et al.
Bone|November 15, 2019
Reduction of fibrillar strain-rate sensitivity in steroid-induced osteoporosis linked to changes in mineralized fibrillar nanostructureL Xi, P De Falco, E Barbieri, et al.
Immunity|January 26, 2021
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinomaJuan Dubrot, Sarah Kate Lane-Reticker, Emily A Kessler, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 12